Indexed keywords
ADALIMUMAB;
ETANERCEPT;
INFLIXIMAB;
METHOTREXATE;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
ADULT;
CLINICAL ARTICLE;
COMBINATION CHEMOTHERAPY;
CONTROLLED STUDY;
CROHN DISEASE;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
FEMALE;
FOLLOW UP;
HUMAN;
LETTER;
MALE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
STRUCTURED QUESTIONNAIRE;
SUPPURATIVE HIDRADENITIS;
TREATMENT DURATION;
TREATMENT OUTCOME;
UNSPECIFIED SIDE EFFECT;
VISUAL ANALOG SCALE;
ADULT;
ANTIBODIES, MONOCLONAL;
FEMALE;
FOLLOW-UP STUDIES;
HIDRADENITIS SUPPURATIVA;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
TIME;
TUMOR NECROSIS FACTOR-ALPHA;
1
38349133918
Long-term efficacy of a single course of infliximab in hidradenitis suppurativa
Mekkes J, Bos JD. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa. Br J Dermatol 2008 158 : 370 4.
(2008)
Br J Dermatol , vol.158
, pp. 370-4
Mekkes, J.1
Bos, J.D.2
2
0041633576
Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa
Sartorius K, Lapins J, Emtestam L, Jemec GBE. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 2003 149 : 211 13.
(2003)
Br J Dermatol , vol.149
, pp. 211-13
Sartorius, K.1
Lapins, J.2
Emtestam, L.3
Jemec, G.B.E.4
3
33749871789
Long-term infliximab for severe hidradenitis suppurativa
Thielen AM, Barde C, Saurat JH. Long-term infliximab for severe hidradenitis suppurativa. Br J Dermatol 2006 154 : 1105 6.
(2006)
Br J Dermatol , vol.154
, pp. 1105-6
Thielen, A.M.1
Barde, C.2
Saurat, J.H.3
4
33947116416
Infliximab for severe hidradenitis suppurativa: Transient clinical efficacy in 7 consecutive patients
Fardet L, Dupuy A, Kerob D et al. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol 2007 56 : 624 8.
(2007)
J Am Acad Dermatol , vol.56
, pp. 624-8
Fardet, L.1
Dupuy, A.2
Kerob, D.3
5
0035034383
Morbidity in patients with hidradenitis suppurativa
von der Werth JM, Jemec GBE. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001 144 : 809 13.
(2001)
Br J Dermatol , vol.144
, pp. 809-13
Von Der Werth, J.M.1
Jemec, G.B.E.2
6
0036677359
Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient
Katsanos KH, Christodoulou DK, Tsianos EV. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient. Am J Gastroenterol 2002 97 : 2155 6.
(2002)
Am J Gastroenterol , vol.97
, pp. 2155-6
Katsanos, K.H.1
Christodoulou, D.K.2
Tsianos, E.V.3
7
33749871789
Long-term infliximab for severe hidradenitis suppurativa
Thielen AM, Barde C, Saurat JH. Long-term infliximab for severe hidradenitis suppurativa. Br J Dermatol 2006 155 : 1105 7.
(2006)
Br J Dermatol , vol.155
, pp. 1105-7
Thielen, A.M.1
Barde, C.2
Saurat, J.H.3
8
37549047980
Is there a role for infliximab in the current therapy of hidradenitis suppurativa? a report of three treated cases
Moschella SL. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases. Int J Dermatol 2007 46 : 1287 91.
(2007)
Int J Dermatol , vol.46
, pp. 1287-91
Moschella, S.L.1
9
33846902650
Variable response of hidradenitis suppurativa to infliximab in four patients
Usmani N, Clayton TH, Everett S, Goodfield MD. Variable response of hidradenitis suppurativa to infliximab in four patients. Clin Exp Dermatol 2007 32 : 204 5.
(2007)
Clin Exp Dermatol , vol.32
, pp. 204-5
Usmani, N.1
Clayton, T.H.2
Everett, S.3
Goodfield, M.D.4
10
34250877720
Infliximab for the treatment of hidradenitis suppurativa
Conflicts of interests: none declared.
Fernández-Vozmediano JM, Armario-Hita JC. Infliximab for the treatment of hidradenitis suppurativa. Dermatology 2007 215 : 41 4.
(2007)
Dermatology , vol.215
, pp. 41-4
Fernández-Vozmediano, J.M.1
Armario-Hita, J.C.2
